Prostate Cancer - Results from #20960

Factors associated with the survival of prostate cancer patients with rectal involvement - Abstract March 20, 2014

Focal therapy for prostate cancer. Rationale, indications and selection - Abstract March 20, 2014

Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer - Abstract March 20, 2014

ERSPC, PLCO studies and critique of Cochrane Review 2013 - Abstract March 19, 2014

Phase III Prostate Cancer Chemoprevention trials - Abstract March 19, 2014

Management of low risk and low PSA prostate cancer: Long term results from the Prostate Cancer Intervention Versus Observation Trial - Abstract March 19, 2014

Long term oncologic outcomes of a Phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high-risk prostate cancer - Abstract March 19, 2014

Epidemiological study of prostate cancer (EPICAP): A population-based case-control study in France - Abstract March 19, 2014

Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies - Abstract March 19, 2014

Measurement equivalence and feasibility of the EORTC QLQ-PR25: Paper-and-pencil versus touch-screen administration - Abstract March 19, 2014

Robot-assisted radical prostatectomy: Modified ultradissection reduces pT2 positive surgical margins on the bladder neck - Abstract March 19, 2014

Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy - Abstract March 19, 2014

Hem-o-lok clip: A neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy - Abstract March 19, 2014

Astellas and Medivation submit supplemental new drug application For XTANDI (enzalutamide) for chemotherapy-naive advanced prostate cancer March 19, 2014

Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancer - Abstract March 18, 2014

Update of the prostate, lung, colorectal, and ovarian cancer screening trial - Abstract March 18, 2014

Screening for prostate cancer: Reflecting on the quality of evidence from the ERSPC and PLCO studies - Abstract March 18, 2014

Measuring Individual Burden of Illness for Depression among prostate cancer patients - Abstract March 18, 2014

Is high-dose leuprorelin acetate effective and safe in Asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial - Abstract March 18, 2014

Charlson Comorbidity Index is an important prognostic factor for long-term survival outcomes in Korean men with prostate cancer after radical prostatectomy - Abstract March 18, 2014

Page 1049 of 1435